Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Peptídeos purificados: conheça o ativo derivado da soja, com ação retinol like, que combate os sinais do envelhecimento precoce


News provided by

Galderma

Oct 02, 2023, 15:52 ET

Share this article

Share toX

Share this article

Share toX

Presente na formulação da linha Cetaphil Healthy Renew, o ingrediente estimula a síntese de colágeno e evita os sinais do envelhecimento na pele

SÃO PAULO, 2 de outubro de 2023 /PRNewswire/ -- É comum relacionar os cuidados com a pele à garantia imediata de uma boa aparência, mas essa estratégia também é fundamental para a manutenção do bem-estar e da saúde ao longo da vida. O envelhecimento pode ser mais intenso na pele de acordo com hábitos de vida e fatores externos. Estresse, sono desregulado, sedentarismo e radiação solar podem favorecer o surgimento precoce dos sinais de envelhecimento, como manchas, rugas e linhas finas. Por isso, a rotina de skincare adequada é uma excelente aliada para o envelhecimento saudável.

Continue Reading

Além da limpeza, hidratação e proteção solar diária, passos básicos e essenciais, há outros ativos que podem agir em camadas mais profundas da pele, de acordo com a necessidade individual de cada um, potencializando os cuidados diários. O retinol, por exemplo, é conhecido por sua ação antissinais, pois repara e previne o envelhecimento cutâneo. Mas, apesar de muito eficaz, pode causar irritação e desconforto em alguns tipos de pele.

Isso não significa que obter esses benefícios é impossível sem o uso do retinol. As fórmulas inovadoras de Cetaphil Healthy Renew, por exemplo, foram desenvolvidas para todos os tipos de pele, inclusive as sensíveis1. A linha voltada para o tratamento dos sinais do envelhecimento conta com uma combinação potente de extrato de edelweiss, extrato de arroz, niacinamida e pantenol, além dos peptídeos purificados (ou glicopeptídeos), que oferecem ação retinol like.

Você conhece a ação retinol like?

Derivados da soja, os peptídeos purificados ajudam a estimular a síntese de colágeno2, inibindo a perda de elasticidade, flacidez e formação de rugas. Sua ação é comparada ao retinol, por isso, é conhecida também como retinol like3,4,5. Segundo a dermatologista Cintia Cunha (CRM MG0045305), "os peptídeos purificados, ou glicopeptídeos, são uma alternativa mais gentil para as peles sensíveis, que podem sofrer com coceira, descamação e vermelhidão ao utilizar retinol".

E para quem busca os benefícios dos glicopetídeos no combate ao envelhecimento precoce, a linha Healthy Renew, lançamento mais recente de Cetaphil, oferece um cuidado completo para as peles 30+. Conheça os detalhes dos produtos:

1.  Solução Micelar Tripla Ação Cetaphil Healthy Renew

Primeiro passo da rotina para o gerenciamento do envelhecimento é a solução micelar, que limpa profundamente a pele6, removendo maquiagem7* e até protetores solares químicos ou minerais resistentes à água8. Também oferece ação antipoluição9* e ainda proporciona e sensação de pele nutrida10. Com um disco de algodão, aplique o produto em todo o rosto e pescoço pela manhã e pela noite. Você pode encontrá-lo nos principais e-commerces e grandes redes de farmácia, em todo o Brasil.

2.  Sérum Facial Cetaphil Healthy Renew

Com efeito antioxidante15, o sérum facial reduz 23% das rugas16*, após 4 semanas de uso, e aumenta a elasticidade da pele em 52%17*. Além disso, age nos 9 sinais de envelhecimento: luminosidade, elasticidade, firmeza, aparência de linhas finas, brilho, hidratação, textura, maleabilidade e uniformidade da pele18. Aplique o produto com a pele limpa em todo rosto e pescoço duas vezes ao dia. Você pode encontrá-lo nos principais e-commerces e grandes redes de farmácia, em todo o Brasil

3.  Sérum para Olhos Cetaphil Healthy Renew

Diminui os sinais de fadiga e olheiras11, reduz a quantidade e a profundidade das rugas12. Reduz 12% das rugas e linhas finas ao redor dos olhos13* e ajuda a melhorar a luminosidade e uniformização do tom de pele14. Você pode inserir o produto em sua rotina de cuidados após limpar a pele e antes de aplicar o hidratante ou sérum facial. Aplique em toda a região dos olhos massageando suavemente. Está disponível nos principais e-commerces e nas grandes redes de farmácia, em todo o Brasil.

4.  Creme Reparador Facial Noturno Cetaphil Healthy Renew 

O creme noturno é clinicamente comprovado para minimizar os sinais de envelhecimento em todos os tipos de pele19-20. Você pode utilizá-lo individualmente ou após a aplicação dos outros produtos da linha. Com a pele limpa, antes de dormir, aplique suavemente em todo o rosto e pescoço. Também está disponível nos principais e-commerces e grandes redes de farmácia, em todo o Brasil.

Lembrando que antes de iniciar o uso de produtos para o cuidado com a pele, é importante consultar um dermatologista.

1 RD.27.SPR.202953 (FIL 1711)
2 Muise A et Desmarais S. Women's Perceptions and Use of "Anti-Aging" Products. Sex Roles (2010). 63, 126–137. https://doi.org/10.1007/s11199-010-9791-5 / Schagen SK. Topical Peptide Treatments with Effective Anti-Aging Results. Cosmetics. (2017) 4(2), 16. https://doi.org/10.3390/cosmetics4020016.
3 Mukherjee S et al. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clinical Interventions in Aging (2006) 1(4), 327-348.
4Ferreira MS et al. Trending Anti-Aging Peptides. Cosmetics (2020) 7, 91; doi:10.3390/cosmetics7040091
5Zasada M, Budzisz E. Retinoids: active molecules influencing skin structure formation in cosmetic and dermatological treatments. Adv Dermatol Allergol (2019) 36(4), 392–397. doi:https://doi.org/10.5114/ada.2019.87443
6 RD.27.STH.202980/P2330 (FIL.1709)
7 RD.27.SPR.202983/P2330 - (FIL.1709); *estudo realizado com 40 participantes
8 RD.27.SPR.205845 - EVALUATION OF THE CLEANSER EFFICACY ON THE REMOVAL OF WATER-RESISTANT SOLAR PRODUCTS (MINERAL AND CHEMICAL FILTERS)
9 RD.27.SPR.202980/P2330 - (FIL.1709); *remove resíduos de poluição, mas não a previne
10 RD.27.SPR.202983/P2330 - (FIL.1709)
11 RD.27.SPR.202953 (FIL 1711)
12-13-14RD.27.SPR.202953 (FIL 1711) / *Estudo realizado com 41 participantes, após 4 semanas de uso
15RD.27.SRE.202950 (FIL 1710)
16RD.27.SPR.202958_Caucasian subjects (FIL 1710; *Estudo realizado com 32 participantes.
17RD.27.SPR.202958_Caucasian subjects (FIL 1710); *Estudo realizado com 40 pessoas, após 8 semanas de uso
18 RD.27.SPR.202958_Asian subjects (FIL 1710)
19 RD.27.SPR.202958_Asian subjects (FIL 1710)
20RD.27.SPR.202962/P2326 - (FIL. 1811)

Sobre a Galderma 
A Galderma é a empresa líder na categoria dedicada ao avanço de soluções para o cuidado da pele, presente em aproximadamente 90 países. Fornecemos um portfólio inovador e baseado em ciência de marcas e serviços premium que abrangem todo o espectro de dermatologia em rápido crescimento por meio de Estética Injetável, Skincare Dermatológico e Dermatologia Terapêutica. Desde nossa fundação em 1981, dedicamos nosso foco e paixão ao maior órgão do corpo humano – a pele – atendendo às necessidades individuais de consumidores e pacientes com resultados superiores em parceria com profissionais de saúde. Estamos avançando a dermatologia para cada história de pele, porque entendemos que a pele em que estamos molda nossas histórias de vida. O portfólio de marcas emblemáticas da Galderma inclui Restylane e Sculptra em Estética Injetável; Cetaphil, Dermotivin e Benzac em Skincare Dermatológico; além dos medicamentos prescritos para Acne e Rosácea em Dermatologia Terapêutica. Para mais informações: www.galderma.com.br e www.galdermaaesthetics.com.br

Foto - https://mma.prnewswire.com/media/2236881/CETAPHIL_LATAM_HEALTHY_RENEW_TONER_160ml_FOP_ID_ef3f580b4045.jpg
Foto - https://mma.prnewswire.com/media/2236878/CETAPHIL_LATAM_HEALTHY_RENEW_FACE_SERUM_30g_FOP_ID_b9f86b7431c3.jpg
Foto - https://mma.prnewswire.com/media/2236877/CETAPHIL_LATAM_HEALTHY_RENEW_EYE_SERUM_15g_FOP_ID_d8a8fab96e98.jpg
Foto - https://mma.prnewswire.com/media/2236879/CETAPHIL_LATAM_HEALTHY_RENEW_NIGHT_CREAM_50g_FOP_45L_ID_44b73a999700.jpg

FONTE Galderma

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Galderma establishes new U.S. headquarters in Miami and strengthens regional leadership

Galderma establishes new U.S. headquarters in Miami and strengthens regional leadership

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the establishment of its new U.S. headquarters in Miami, Florida,...

GALDERMA LAUNCHES "SCRATCH RESISTANCE" CAMPAIGN TO VALIDATE THE PHYSICAL AND EMOTIONAL BURDENS OF ATOPIC DERMATITIS

GALDERMA LAUNCHES "SCRATCH RESISTANCE" CAMPAIGN TO VALIDATE THE PHYSICAL AND EMOTIONAL BURDENS OF ATOPIC DERMATITIS

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the launch of "Scratch Resistance," its new broadcast advertisement...

More Releases From This Source

Explore

Cosmetics and Personal Care

Cosmetics and Personal Care

Health Care & Hospitals

Health Care & Hospitals

Household, Consumer & Cosmetics

Household, Consumer & Cosmetics

New Products & Services

New Products & Services

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.